What is MiTeGen?
MiTeGen operates at the intersection of advanced engineering and structural biology, specializing in the design, manufacture, and distribution of high-performance tools for cryo-electron microscopy, crystallization, and X-ray diffraction. The company provides essential infrastructure for sample handling and cryocooling, catering to a diverse clientele that spans academic institutions, government laboratories, and industrial research facilities. With a robust portfolio that includes custom engineering services and comprehensive lab starter kits, MiTeGen has established itself as a vital partner in the scientific discovery process. Its products are widely recognized for their reliability, having been cited in over 6,700 peer-reviewed research articles, which highlights the company's deep integration into the global research ecosystem.
How much funding has MiTeGen raised?
MiTeGen has raised a total of $142K across 1 funding round:
Debt
$142K
Debt (2021): $142K with participation from PPP
Key Investors in MiTeGen
PPP
Public-Private Partnership
What's next for MiTeGen?
With this late-stage funding, MiTeGen is poised to solidify its market leadership by scaling its manufacturing capabilities and investing in next-generation research technologies. The strategic roadmap likely involves expanding its New Lab Program to capture emerging research markets while simultaneously refining its custom engineering services to meet the increasing demand for specialized cryo-electron microscopy solutions. By maintaining its commitment to precision and innovation, the company is well-positioned to capitalize on the growing global emphasis on structural biology and drug discovery. Future growth will likely be driven by the continued adoption of its proprietary tools in high-throughput screening environments, ensuring that MiTeGen remains an indispensable asset to the scientific research community for years to come.
See full MiTeGen company page
